Physician Scientist | Translational Research Leader | Precision Medicine Innovator

I am a physician scientist and epidemiologist with over 15 years of experience at the forefront of human genetics, translational research, and precision medicine. Accredited in Pharmaceutical Medicine, I combine clinical expertise with a passion for leveraging large-scale data to transform disease understanding and accelerate drug discovery and development.

Key Expertise:

Translational Research: Integrating genomic, proteomic, and metabolomic data to uncover disease mechanisms, evaluate therapeutic targets, and identify biomarkers for diagnosis, prognosis, and treatment response.
Precision Medicine: Developing patient-centered approaches by combining genetics e.g. with polygenic risk scores, pharmacogenetics, and multi-omics to optimize therapies tailored to individual needs.
Causal Inference in Drug Discovery: Applying Mendelian randomization and advanced methodologies to identify and validate therapeutic targets, particularly in cardiovascular and metabolic diseases.

Career Highlights:

Leadership in genetics research at 23andMe, where I explore genetic variants associated with drug response (e.g., semaglutide) to inform personalized medicine and drug development.
Faculty roles at the University of Oxford and the University of Pennsylvania, directing multidisciplinary teams conducting translational research bridging human genetics and disease biology.
Extensive use of omics data—genomics, proteomics, metabolomics—to uncover causal biomarkers, elucidate disease mechanisms, and prioritize therapeutic targets for drug development.
Proven track record of publishing translational discoveries, creating a foundation for innovative therapeutic strategies.

Leadership and Collaboration:
With a collaborative mindset, I build and lead multidisciplinary teams of clinicians, scientists, and data experts. My leadership emphasizes innovation, mentorship, and teamwork to solve complex biomedical challenges.

Relevance to Drug Development:
My work supports early-stage drug development by identifying genetically supported targets, uncovering mechanisms of action, and defining biomarker signatures to de-risk therapeutic strategies.

What Drives Me:
I am passionate about transforming data into actionable insights to improve health outcomes. By bridging science and medicine, I aim to enable precision therapies and drive innovation in drug development